Health
Enzychem Lifesciences files patent for coronavirus treatment
The biopharmaceutical company headquartered in Seoul expands the legal protection of EC-18 drug to the USA after the starting trial in South Korea On March 17, 2020, Enzychem Lifesceices announced that it was advancing a domestic clinical trial of EC-18, a new coronavirus treatment candidate, in…
Mario Vincenzo La Rocca